The U.S. Food & Drug Administration (FDA) has announced that women implanted with the Bard Avaulta Bladder Sling may face an increased risk of developing serious complications including mesh erosion, infection and pelvic pain. Over the past several years, the FDA has received thousands of complaints associated with transvaginal mesh devices like the Avaulta Bladder Sling. Although the administration first described these potential complications as rare, it has since advised the public that patients who are implanted transvaginally with surgical mesh have a much greater risk of developing severe side effects than those treated with more tradition stitching techniques.
Free Confidential Case Evaluation: If you or a loved one has been injured or suspect that you may have complications directly linked to the Bard Avaulta Bladder Sling, you should contact our law firm immediately. You may be entitled to compensation by filing a lawsuit and we can help.
What’s the Problem with the Avaulta Bladder Sling?
The Avaulta Bladder Sling was designed to treat pelvic organ prolapse (POP), a common condition that occurs when a pelvic organ drops from its normal position and pushes against the vaginal walls. During surgery, the sling is implanted in the anterior or posterior vaginal compartment. However, despite demonstrating considerable effectiveness at treating POP, many patients claim they have been exposed to other, more serious complications after being implanted with the devices.
Many recipients of the Bard Avaulta Bladder Sling believed that their complications were normal until the FDA released a warning regarding these products in October 2008. This warning cited a large number of complaints from women who were implanted with a transvaginal mesh product, including the Avaulta Bladder Sling, during procedures to correct urinary issues. The complaints cited complications including:
- erosion through vaginal epithelium
- pain, including dyspareunia
- urinary problems
- recurrence of prolapse and/or incontinence
- bowel, bladder, and blood vessel perforation
- vaginal scarring
- mesh erosion
Avaulta Bladder Sling Litigation
Each Avaulta Bladder Sling lawsuit filed against Bard involves similar allegations. The company has been blamed for failing to warn the public and medical communities about the potential complications associated with the device. Bard has also been accused of designing a defective product; it is believed that the mesh prevents the surrounding tissue from obtaining proper oxygen and nutrients, which can interfere with the healing process. This may lead to the development of Avaulta Bladder Sling complications, and require the need for painful revision surgeries to remove the device.
Do I Have an Avaulta Bladder Sling Lawsuit?
The Medical Device Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Avaulta Bladder Sling lawsuits. We are handling individual litigation nationwide and currently accepting new Avaulta Bladder Sling lawsuits in all 50 states.
Free Avaulta Bladder Sling Lawsuit Evaluation: Again, if you or a loved one has been injured or suspect that you may have complications directly linked to the Bard Avaulta Bladder Sling, you should contact our law firm immediately. You may be entitled to compensation by filing a lawsuit and we can help.